Ameritas Advisory Services’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
9,590
-229
| -2% | -$9.29K | 0.02% | 566 |
|
|
2025
Q1 | $430K | Sell |
9,819
-193
| -2% | -$8.45K | 0.02% | 605 |
|
|
2024
Q4 | $430K | Buy |
10,012
+146
| +1% | +$6.28K | 0.01% | 628 |
|
|
2024
Q3 | $438K | Sell |
9,866
-715
| -7% | -$31.7K | 0.02% | 575 |
|
|
2024
Q2 | $421K | Sell |
10,581
-340
| -3% | -$13.5K | 0.02% | 631 |
|
|
2024
Q1 | $471K | Sell |
10,921
-3,397
| -24% | -$146K | 0.02% | 569 |
|
|
2023
Q4 | $596K | Buy |
14,318
+925
| +7% | +$38.5K | 0.03% | 392 |
|
|
2023
Q3 | $532K | Buy |
+13,393
| New | +$532K | 0.03% | 487 |
|
|
2023
Q2 | – | Sell |
-11,339
| Closed | -$480K | – | 2559 |
|
|
2023
Q1 | $480K | Buy |
11,339
+57
| +0.5% | +$2.41K | 0.02% | 484 |
|
|
2022
Q4 | $462K | Sell |
11,282
-1,528
| -12% | -$62.6K | 0.02% | 557 |
|
|
2022
Q3 | $514K | Sell |
12,810
-314
| -2% | -$12.6K | 0.03% | 426 |
|
|
2022
Q2 | $551K | Sell |
13,124
-1,474
| -10% | -$61.9K | 0.03% | 427 |
|
|
2022
Q1 | $661K | Buy |
14,598
+1,306
| +10% | +$59.1K | 0.02% | 433 |
|
|
2021
Q4 | $613K | Buy |
+13,292
| New | +$613K | 0.02% | 447 |
|